This website is intended for healthcare professionals.

IDA places a substantial burden on patients1,2

Anaemia affects around a third of the world’s population and half of cases are due to ID1

IDA negatively impacts many aspects of patients’ HRQoL2

A patient with Crohn’s disease experience of suffering from IDA
If I suffer from iron deficiency, I am very limited in my private life but especially in my professional activities, because I am self-employed. I tire quickly, I don’t want to get up in the morning, I don’t want to go to work… I just want to sleep
A patient with Crohn’s disease experience of suffering from IDA

Oral ferrous iron salts are 2.3 times more likely to cause gastrointestinal AEs vs placebo3

The most common gastrointestinal AEs with oral
ferrous iron salts were:3

  • Nausea
  • Abdominal pain
  • Diarrhoea
  • Constipation

There is no significant dose-response effect on gastrointestinal AEs with oral ferrous iron salts3

IV iron can be time-consuming and resource-intensive to administer4–8

Each infusion costs healthcare professionals time for administration and monitoring, and many patients also have the extra burden of travel time and expenses4–9

IV iron can only be administered by staff trained to identify and manage anaphylactic reactions, and in settings where full resuscitation facilities are available4–8

AE, adverse event; HRQoL, health-related quality of life; ID, iron deficiency; IDA, iron deficiency anaemia; IV, intravenous.

References:

  1. Lopez A, et al. Lancet 2016;387:907–916.
  2. Strauss WE, et al. JCSO 2016;14(8):342–350.
  3. Tolkien Z, et al. PLoS One 2015;10(2):e0117383.
  4. CosmoFer® UK Summary of Product Characteristics. January 2020. Available at: https://www.medicines.org.uk/emc/product/48. Accessed April 2021.
  5. Diafer® UK Summary of Product Characteristics. August 2020. Available at: https://www.medicines.org.uk/emc/product/5324. Accessed April 2021.
  6. Ferinject® UK Summary of Product Characteristics. October 2020. Available at: https://www.medicines.org.uk/emc/product/5910. Accessed April 2021.
  7. Monofer® UK Summary of Product Characteristics. May 2020. Available at: https://www.medicines.org.uk/emc/product/5676. Accessed April 2021.
  8. Venofer® UK Summary of Product Characteristics. December 2020. Available at: https://www.medicines.org.uk/emc/product/5911. Accessed April 2021.
  9. Bager P, et al. J Crohns Colitis 2010;4(4):427–430.

Hi, I'm Eric.
Click here to ask me a question about FERACCRU®